Financials
Financial year 2025
Ipsen from Brussel, company number BE0422650477, closed financial year 2025 with a result of € 4.2 million after tax. For that financial year Ipsen recorded revenue of € 71.3 million and equity of € 119.9 million. Compared with financial year 2024, the result moved from € 5.1 million to € 4.2 million. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 17, 2026.
€ 119.9 million
▲ 4% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 4.2 million
▼ 18% vs 2024
Profit after tax over the fiscal year.
€ 252
▼ 28% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 41.1 million.
People and assets in 2025
39.9
▼ 3 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 9.5 million
▲ 6% vs 2024
€ 237,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 75,455
▲ 264% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 11.6 million
▲ 46% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 93 days on average.
€ 2.9 million
▲ 55% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 58,240,729 | € 66,183,644 | € 69,491,262 | € 71,316,801 | ▲ 3% |
| Profit after taxes | € 1,386,530 | € 3,773,369 | € 5,068,339 | € 4,170,050 | ▼ 18% |
| Equity | € 106,872,730 | € 110,646,098 | € 115,714,437 | € 119,884,487 | ▲ 4% |
| Total debts | € 17,578,675 | € 15,876,318 | € 9,795,319 | € 14,476,152 | ▲ 48% |
| Cash | - | - | € 350 | € 252 | ▼ 28% |
| Retained profit | € 28,124,730 | € 31,898,098 | € 36,966,437 | € 41,136,487 | ▲ 11% |
| Bank debt | € 283 | € 0 | € 0 | € 0 | |
| Balance sheet total | € 124,508,618 | € 126,522,416 | € 125,509,757 | € 134,360,639 | ▲ 7% |
| Employees (FTE) | 39.7 | 42.1 | 42.9 | 39.9 | ▼ 3 |
Key figures of Ipsen, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Ipsen?
What happened at Ipsen in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Rafael Giglio stepped down as director. NBB
- Catherine Abi-Habib stepped down as director. NBB
- Jana Smidlova stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 4.2 million (▼ 18% vs 2024). Source: NBB ↗
- Rafael Giglio became a director. NBB
- Abla Abrial stepped down as director. NBB
- Catherine Abi-Habib became a director. NBB
- Agathe Pallière-Caline stepped down as director. NBB
In short
From € 1.4 million profit in 2022 to € 4.2 million profit in 2025.
Paid € 5.3 million in corporate taxes since 2022.
Best year ever: 2024, with € 5.1 million profit.
Pays suppliers within 93 days on average.
A new publication or filing at Ipsen? We notify you, reason included.
Follow IpsenDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The shares are held by Ipsen Pharma SAS (89.9%), Ipsen Pharma SA (10.1%) and Ipsen SA (0%).
Directors
According to the 2025 annual accounts
Jana Smidlova
Director
since 2023 · until 2029
Rafael Giglio
Director
since 2025 · until 2031
Abla Abrial
Director
since 2023 · until 2025
Catherine Abi-Habib
Director
since 2025 · until 2031
Agathe Pallière-Caline
Director
since 2023 · until 2025
Shareholders
Ipsen Pharma SAS
89.9%
Ipsen Pharma SA
10.1%
Ipsen SA
0%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Treurenberg 2-4 box 4
1000 Brussel
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0422.650.477
- VAT number
- BE 0422.650.477
- Registered office
- Treurenberg 2-4 bus 4, 1000 Brussel
- Names & denominations
- Ipsen
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 9 April 1982
- Peppol
- Active · Active since 25 Sept 2026
- Activities · NACE
Vervaardiging van geneesmiddelen
Groothandel in farmaceutische en medische artikelen
Groothandel in farmaceutische producten